PEPIDH1M

N/A

Report date: 2026/04/30 20:00:20

Base Information

Drug NamePEPIDH1M
Drug Alias NameCytomegalovirus vaccine (Duke University Medical Center)PEP-CMV Vaccine (Duke University Medical Center)PEP-CMVPEPIDH1MPEPIDH-1-M
ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccineVaccines > Development/production technology > Synthetic peptide vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsDiffuse midline gliomaMedulloblastomaEpendymoma +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesDuke University Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesDuke University Medical CenterUnsw SydneyWashington University School Of Medicine +[5] 
Inactive CompaniesUniversity Of Florida
Active IndicationsDiffuse midline gliomaMedulloblastomaEpendymoma +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A